Clinical Trial Update: Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a lifestyle intervention to improve insulin sensitivity and cardiovascular risk markers in prostate cancer survivors has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED